What is the Purpose of this Study?
Primary feasibility objective: 1. To evaluate the rate of intervention completion among consented participants. Secondary efficacy objectives: 2. To evaluate the change in self-efficacy from baseline to 3 months after delivery of the Proactive Costs of Care (PCOC) intervention. Secondary safety objective: 3. To evaluate the change in financial distress from baseline to 3 months after delivery of the PCOC intervention. Exploratory objectives: 4. To evaluate the change in health insurance literacy from baseline to 3 months after delivery of the PCOC intervention. 5. To evaluate satisfaction with the PCOC intervention 3 months after delivery of the PCOC intervention.
Eligibility
- * Individuals 18 years old or older are included.
- * Individuals diagnosed with gynecologic cancer
- * On active systemic therapy within 30 days of enrollment
- * Receiving treatment at Cedars-Sinai Medical Center
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
An open, single-arm, single-site study to evaluate the Proactive Costs of Care intervention delivered by a trained lay educator to test feasibility with the goal of improving self-efficacy among patients with gynecologic cancer on active therapy